Abstract:Objective:To explore the efficacy and influencing factors of radiofrequency ablation (RFA) in the treatment of colorectal cancer liver metastases (CRLM).Methods:The clinical and imaging data of 281 patients (477 intrahepatic metastatic tumors) who received percutaneous RFA treatment in Sir Run Run Shaw Hospital, Zhejiang University School of Medicine from December 2009 to December 2020 were retrospectively analyzed. Factors that may affect the efficacy of RFA were recorded, including carcinoembryonic antigen (CEA), differentiation, extrahepatic metastasis, tumor location and size, complications and other information. Patients were followed up through hospital admissions, telephone, etc. The primary endpoints were overall survival (OS) and local tumor progression-free survival (LTPFS). Univariate and multivariate logistic regression models were used to identify predictors of residual tumor. Univariate and multivariate Cox proportional hazards regression were used to identify the influencing factors of LTPFS and OS. The median LTPFS and OS were estimated by the Kaplan-Meier curve and compared by the log-rank test.Results:After RFA, 68 (14.3%) tumor residues were observed. Multivariate logistic regression showed that the risk factors for residual tumor were size ≥20 mm, high-risk and perivascular location, and minimal ablative margin<5 mm. During the follow-up period, the main complication rate was 4.3% (12/281) and the fatality rate was 31.3% (88/281). At the same time, local tumor progression was found in 167 (35.0%) lesions post-RFA. The median time of LTPFS and OS estimated by the Kaplan Meier method were 35.0 (95%CI 26.53-43.48) and 44.0 (95%CI 29.70-58.30) months, respectively. The cumulative proportion of LTPFS and OS were 37.2% and 40.4% respectively in the 5th year. Multivariate Cox proportional hazard regression showed that CEA≥30 ng/ml, tumor size ≥20 mm, and minimal ablative margin<5 mm were risk factors for LTPFS; extrahepatic metastasis, tumor burden>30 mm, and lesion with minimal ablative margin<5 mm were independent risk factors for OS; re-intervention was an independent protective factor for OS.Conclusions:Adequate ablative margin and less tumor burden were beneficial to local tumor control and long-term survival of patients in the RFA treatment; the existence of extrahepatic metastasis was an important risk factor for OS, and re-interventional therapy was beneficial to extend OS.

Multifactorial Analysis of Clinical Prognosis of Liver Metastasis and Vascular Intervention Combined with Ablation in Colorectal Cancer

Does Primary Tumor Location Impact the Prognosis of Colorectal Liver Metastases Patients after Microwave Ablation? - Lessons from 10 Years’ Experience

The Management of Colorectal Cancer with Synchronous Liver Metastases

Successful Treatment of Colorectal Liver Metastasis Harboring Intrahepatic Cholangiocarcinoma

Clinical Outcome of Ultrasound-Guided Percutaneous Microwave Ablation on Colorectal Liver Metastases.

Analysis of therapeutic effect and influencing factors of radiofrequency ablation for colorectal cancer liver metastases

Effect of Preoperative Hepatic and Regional Arterial Chemotherapy on Metachronous Liver Metastasis after Curative Colorectal Cancer Resection: A Prospective, Multicenter, Randomized Controlled Trial

Impact of Timing and Cycles of Systemic Chemotherapy on Survival Outcome of Colorectal Liver Metastases Patients Treated by Percutaneous Microwave Ablation

Combined modality therapy strategies for colon cancer liver metastasis

Analysis of Prognostic Factors of Colorectal Cancer Liver Metastasis after Microwave Ablation

Multivariate Regressive Analysis of Prognosis of Liver Metastases from Colorectal Cancer

Multi-modality Treatment of Colorectal Liver Metastases.

Analysis of Prognostic Factors of Hepatic Metastasis of Colorectal Cancer and Influence of the Therapy on Long-Term Survival

[Prognostic analysis of 220 colorectal cancer patients with synchronous liver metastases].

Colorectal liver metastases: a retrospective analysis of 120 patients from a single-institution

Advancement of the combined therapy of colorectal liver metastasis

Current Situation and Prospect of Multi-modality Treatment for Colorectal Liver Metastases

Long-term Results and Prognostic Affecting Factors of Combined Interventional Therapies for Treatment of Intermediate and Advanced Primary Liver Cancer

Analysis of Prognostic Factors for Colorectal Cancer Patients with Liver Metastases

Outcome of Patients with Colorectal Liver Metastasis: Analysis of 1613 Consecutive Cases

Prognostic factors of 91 patients with simultaneous liver metastases from colorectal cancer